Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Systemic Therapy and Cytoreductive Surgery With HIPEC Versus Upfront Cytoreductive Surgery With HIPEC Alone for Isolated Resectable Colorectal Peritoneal Metastases: a Multicentre, Open-label, Parallel-group, Phase II-III, Randomised Superiority Study

NCT02758951 is registered in ClinicalTrials.gov with Koen Rovers as lead sponsor.

NCT NCT02758951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02758951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Systemic Therapy and Cytoreductive Surgery With HIPEC Versus Upfront Cytoreductive Surgery With HIPEC Alone for Isolated Resectable Colorectal Peritoneal Metastases: a Multicentre, Open-label, Parallel-group, Phase II-III, Randomised Superiority Study
Lead sponsor
Koen Rovers
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
June 1, 2017
Completion date
June 1, 2029
Enrollment
358 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, colorectal cancer, colorectal carcinoma, colorectal neoplasm, colorectal neoplasms malignant, peritoneal cancer, peritoneal carcinomatosis, peritoneal metastases, peritoneal neoplasm malignant secondary, peritoneal neoplasm malignant secondary carcinomatosis, peritoneal neoplasms